- Home
- EVO vs ASIC Comparison
EVO vs ASIC Comparison
Compare EVO & ASIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- ASIC
- Stock Information
- Founded
- EVO 1993
- ASIC 2018
- Country
- EVO Germany
- ASIC United States
- Employees
- EVO N/A
- ASIC N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- ASIC Property-Casualty Insurers
- Sector
- EVO Health Care
- ASIC Finance
- Exchange
- EVO Nasdaq
- ASIC Nasdaq
- Market Cap
- EVO 1.4B
- ASIC 1.2B
- IPO Year
- EVO 2021
- ASIC 2025
- Fundamental
- Price
- EVO $3.76
- ASIC $22.76
- Analyst Decision
- EVO Buy
- ASIC
- Analyst Count
- EVO 2
- ASIC 0
- Target Price
- EVO $5.90
- ASIC N/A
- AVG Volume (30 Days)
- EVO 159.9K
- ASIC 550.0K
- Earning Date
- EVO 08-13-2025
- ASIC 01-01-0001
- Dividend Yield
- EVO N/A
- ASIC N/A
- EPS Growth
- EVO N/A
- ASIC N/A
- EPS
- EVO N/A
- ASIC 0.12
- Revenue
- EVO $851,944,444.00
- ASIC $350,888,000.00
- Revenue This Year
- EVO $10.08
- ASIC N/A
- Revenue Next Year
- EVO $10.99
- ASIC N/A
- P/E Ratio
- EVO N/A
- ASIC $198.15
- Revenue Growth
- EVO 1.50
- ASIC 42.48
- 52 Week Low
- EVO $2.84
- ASIC $22.00
- 52 Week High
- EVO $5.64
- ASIC $25.30
- Technical
- Relative Strength Index (RSI)
- EVO 41.37
- ASIC N/A
- Support Level
- EVO $4.06
- ASIC N/A
- Resistance Level
- EVO $4.44
- ASIC N/A
- Average True Range (ATR)
- EVO 0.11
- ASIC 0.00
- MACD
- EVO -0.04
- ASIC 0.00
- Stochastic Oscillator
- EVO 0.00
- ASIC 0.00
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About ASIC Ategrity Specialty Insurance Company Holdings Common Stock
Ategrity Specialty Insurance Co Holdings Formerly Ategrity Specialty Holdings LLC is a specialty insurance company dedicated to providing excess and surplus products to small to medium-sized businesses across the United States. It offers property and casualty insurance solutions tailored to meet the needs of SMBs. The company focuses on are Real Estate, Hospitality, Construction, and Retail.